Sleeping Beauty Transposase Antibody [CoraFluor™ 1]
Novus Biologicals, part of Bio-Techne | Catalog # AF2798CL1
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Concentration
Product Specifications
Immunogen
Specificity
Clonality
Host
Isotype
Description
CoraFluor(TM) 1, amine reactive
CoraFluor(TM) 1, thiol reactive
For more information, please see our CoraFluor(TM) TR-FRET technology flyer.
Scientific Data Images for Sleeping Beauty Transposase Antibody [CoraFluor™ 1]
Product Feature: CoraFluor Probes for TR-FRET
CoraFluor™ 1, amine reactive (Catalog:7920) and CoraFluor™ 2, amine reactive (Catalog # 7950) are terbium-based probes that have been developed for use as TR-FRET donors. They emit wavelengths compatible with commonly used fluorescent acceptor dyes such as BODIPY® (or BDY) and Janelia Fluor® dyes, FITC (Catalog # 5440), TMR and Cyanine 5 (Catalog # 5436). CoraFluor™ fluorescence is brighter and more stable in biological media than existing TR-FRET donors, leading to enhanced sensitivity and improved data generation. CoraFluor™ 1 exhibits excitation upon exposure to a 337 nm UV laser.Applications for Sleeping Beauty Transposase Antibody [CoraFluor™ 1]
Immunohistochemistry
Western Blot
Formulation, Preparation, and Storage
Purification
Formulation
Preservative
Concentration
Shipping
Stability & Storage
Background: Sleeping Beauty Transposase
The SB transposase is an active transposase reconstructed from consensus sequences of several mutated and inactive Tc1/mariner family transposase genes in salmonid fish. The transposase is an element of a transposon that catalyzes the excision of transposon DNA from its original location and promotes its reintegration elsewhere in the genome.
Additional Sleeping Beauty Transposase Products
Product Documents for Sleeping Beauty Transposase Antibody [CoraFluor™ 1]
Product Specific Notices for Sleeping Beauty Transposase Antibody [CoraFluor™ 1]
CoraFluor (TM) is a trademark of Bio-Techne Corp. Sold for research purposes only under agreement from Massachusetts General Hospital. US patent 2022/0025254
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.